Compare FENC & TYGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FENC | TYGO |
|---|---|---|
| Founded | 1996 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 263.3M | 281.4M |
| IPO Year | 2010 | 2021 |
| Metric | FENC | TYGO |
|---|---|---|
| Price | $7.55 | $3.42 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $15.00 | $6.00 |
| AVG Volume (30 Days) | 115.4K | ★ 418.0K |
| Earning Date | 01-01-0001 | 05-22-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 96.67 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $47,538,000.00 | ★ $54,014,000.00 |
| Revenue This Year | N/A | $27.36 |
| Revenue Next Year | $70.78 | $25.52 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 123.69 | N/A |
| 52 Week Low | $4.68 | $0.58 |
| 52 Week High | $9.92 | $4.50 |
| Indicator | FENC | TYGO |
|---|---|---|
| Relative Strength Index (RSI) | 39.52 | 48.51 |
| Support Level | $7.45 | $3.19 |
| Resistance Level | $8.27 | $4.41 |
| Average True Range (ATR) | 0.45 | 0.39 |
| MACD | -0.12 | -0.06 |
| Stochastic Oscillator | 10.51 | 21.87 |
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.
Tigo Energy Inc designs solar power conversion and storage products that provide customers with more choice and flexibility. Its mission is to deliver smart hardware and software solutions that enhance safety, increase energy yield, and lower operating costs of residential, commercial, and utility-scale solar systems. Geographically the company generates revenue from EMEA, Americas, and APAC.